Bacillus anthracis protective antigen Antibody (BAP0102) [DyLight 488]

Product Discontinued

Bacillus anthracis protective antigen Antibody (BAP0102) [DyLight 488] Summary

• Immunogen: Hybridoma clone has been derived from hybridization of Sp2/0 myeloma cells with spleen cells of Balb/c mice immunized with highly purified protective antigen of Bacillus anthracis
• Specificity: This is specific to the Protective antigen of Bacillus anthracis.This does not cross-react with lethal factor antigen of B. anthracis, Y. Pestis, F. Tularensis, Toxoplasma gondii.
• Isotype: IgG2b
• Clonality: Monoclonal
• Host: Mouse
• Purity: Protein G purified

Applications/Dilutions

• Dilutions:
  • ELISA
  • Sandwich ELISA
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Protein G purified

Notes

Dylight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.

Alternate Names for Bacillus anthracis protective antigen Antibody (BAP0102) [DyLight 488]

• anthrax PA
• Anthrax toxins translocating protein
• PA 83
• PA
• PA83
• PAG
• Paga
• Protective antigen

Background

Anthrax toxins are composed of three distinct proteins, a protective antigen (PA), a lethal factor (LF) and an edema factor (EF). None of these proteins are toxic by themselves and several studies indicate that the anthrax toxin has the familiar A-B enzymatic binding structure, with PA acting as the binding domain and EF and/or LF acting as the active fragments.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.